ZYNE V-Shape reversal

20 มี.ค. 2020

Looking to break above Gann line, then close the bear gap before moving back to more reasonable levels. I got in a $2.65 yesterday. Looking good so far. Many catalysts ahead for Zynerba in 2020, and trial results so far, are in line with what GWPH met before they got Epidiolex approved.

With and NDA, I believe ZYNE would be a $100+ stock.